Compound N - (2 - (6 - fluoro - 1 - (indol-3-yl) ethyl) - 3 - (2,2,3,3-tetrafluoropropoxy) benzylamine or its Salt, 5 HT6 receptor antagonist； Pharmaceutical Composition and use in the treatment of Alzheimer's disease.

• 收藏
• 分享

专利权人:

H. LUNDBECK A/S

发明人:

SCHMIDT, ELLEN,AREBERG, JOHAN

申请号：

CL2015000578

公开号：

CL2015000578A1

申请日:

2015.03.06

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.SE DESCRIBE EL USO DEL COMPUESTO N-(2-(6-FLUORO-1H-INDOL-3-IL)ETIL)-3-(2,2,3,3-TETRAFLUOROPROPOXI)BENCILAMINA, ANTAGONISTA DEL RECEPTOR 5-HT6, PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/